TRADE-Testosterone Replacement and Dutasteride Effectiveness
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether the combination of the male
hormone testosterone [T] in gel form and the oral drug dutasteride [D], used to shrink large
prostate glands can safely reduce the size of the prostate gland and symptoms of prostate
enlargement (called benign prostatic hyperplasia [BPH]) compared to T treatment alone in men
with low testosterone (called hypogonadism).
Phase:
Phase 4
Details
Lead Sponsor:
University of Washington
Collaborators:
GlaxoSmithKline Seattle Institute for Biomedical and Clinical Research Solvay Pharmaceuticals VA Office of Research and Development